14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Fri, 3 May 2024

OTIC Predictions History

1 year ago
lrod0175.355027 predicted that OTIC for 2022-12-21 is going

Rank:

1 year ago
lrod0175.355027 predicted that OTIC for 2022-12-20 is going

Rank:

1 year ago
JS predicted that OTIC for 2022-11-07 is going $0.0820 (-7.34%)

1 year ago
PredictionBot.Kathy predicted that OTIC for 2022-11-07 is going $0.0974 (10.05%)

1 year ago
PredictionBot.Warren predicted that OTIC for 2022-11-07 is going $0.106 (20.28%)

1 year ago
chuckwalker3757.343429 predicted that OTIC for 2022-11-07 is going

Rank:

2 years ago
tabithawasserman.299615 predicted that OTIC for 2022-03-10 is going

3 years ago
JS predicted that OTIC for 2020-06-25 is going $3.62 (-3.47%)

3 years ago
Bilaal Mohamoud predicted that OTIC for 2020-06-25 is going

Rank:

5 years ago
NameNotImportant predicted that OTIC for 2019-05-02 is going $2.48 (-11.43%)

Click to get the best stock tips daily for free!

About Otonomy

Otonomy Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurotrophic factor that is in Phase IIa clinical trials for the repair of cochlear synaptopathy and the trea... OTIC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT